A New $16,000 Postpartum Depression Drug Is Here. How Will Insurers Handle It?

Zuranolone, a new treatment for postpartum depression, has hit the market with promising results but faces challenges in insurance coverage. Many insurers have yet to establish clear guidelines for when they will cover the drug, potentially limiting its accessibility. Previous experiences with a similar drug, brexanolone, showed restrictive policies that hindered patient access. Advocates are…

Read More

Relyvrio patients react with fear, worry

A Phase 3 trial of Amylyx Pharmaceuticals’ ALS drug, Relyvrio, failed to show benefit compared to placebo, disappointing the ALS community. Previous positive results from a Phase 2 study did not replicate in a larger group, impacting patients like Gwen Petersen, who saw stabilization on the drug. Concerns arise about insurance coverage and future ALS…

Read More

Physician associates: a pause in rollout is needed

The Royal College of Physicians is set to hold an extraordinary general meeting to debate the role of Physician Associates and Medical Associate Professions. This debate has escalated due to concerns that were previously ignored, leading to uncertainty among PA colleagues. Five motions are up for debate, including the scope of practice, training opportunities, and…

Read More

New sprayable gel promises safer endoscopic surgeries

Researchers at MIT have developed a gel called GastroShield that can be sprayed onto surgical sites during endoscopic procedures to prevent delayed bleeding and reinforce tissue integrity. The gel forms a protective layer that lasts for three to seven days, promoting tissue healing post-surgery. This gel is designed to interact with tissue through various interactions…

Read More

How Exercise Can Help Ease Osteoarthritis Joint Pain

Dianne Rosenbluth, 81, struggled with osteoarthritis and joint pain, but found relief through exercise and lifestyle changes. Regular physical activity, including low-intensity activities like walking, have helped ease her symptoms and improve her overall quality of life. Experts agree that a measured approach to exercise can benefit those with osteoarthritis, reducing pain, stiffness, and swelling….

Read More

Abbott Recalls HeartMate Touch System

Abbott has recalled the HeartMate Touch Communication System due to potential issues with the HeartMate 3 left ventricular assist device where the pump may unexpectedly stop or start. This can lead to serious adverse health consequences including lightheadedness, loss of consciousness, and even death. The FDA has classified this recall as Class I, the most…

Read More

Use of benzodiazepines for seizure control in kids tied to future risk of polytherapy, reveals study

A study has found that the use of benzodiazepines for controlling seizures in children may increase the risk of being on multiple medications in the future. This information was revealed through research on the long-term effects of benzodiazepine use in pediatric patients. The study suggests that caution should be exercised when prescribing benzodiazepines for seizure…

Read More
error: Content is protected !!